N,N,2-Trimethyl-6-(piperazin-1-yl)pyrimidin-4-amine

Catalog No. :
ACKQRE644
CAS No. :
1706441-11-3
Molecular Formula :
C11H19N5
Molecular Weight :
221.31

IUPAC Name:N,N,2-trimethyl-6-(piperazin-1-yl)pyrimidin-4-amine

N,N,2-Trimethyl-6-(piperazin-1-yl)pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$445.00Login to see priceInquiryInquiry
1g97%$1396.00Login to see priceInquiryInquiry
5g97%$2912.00Login to see priceInquiryInquiry
10g97%$3995.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,N,2-Trimethyl-6-(piperazin-1-yl)pyrimidin-4-amine
IUPAC NameN,N,2-trimethyl-6-(piperazin-1-yl)pyrimidin-4-amine
Molecular FormulaC11H19N5
Molecular Weight221.31
SMILESCC1=NC(N2CCNCC2)=CC(N(C)C)=N1
InChI KeyDEURNQSDFBPVJP-UHFFFAOYSA-N
SynonymN,N,2-trimethyl-6-(piperazin-1-yl)pyrimidin-4-amine;Dimethyl-(2-methyl-6-piperazin-1-yl-pyrimidin-4-yl)-amine;4-Pyrimidinamine, N,N,2-trimethyl-6-(1-piperazinyl)-
CAS No.1706441-11-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKQRE644 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACCFNO831 route compound structure diagram
    ACCFNO83158514-89-9 In Stock
  4. Then
  5. ACKQRE644 route product structure diagram
    ACKQRE6441706441-11-3
Inquiry

2. ACKQRE644 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQRE644 route product structure diagram
    ACKQRE6441706441-11-3
Inquiry

Comments (0)